T3 - Technion Technology Transfer Revenue
Venture Capital and Private Equity Principals • 
Haifa, Haifa District, Israel • 1-10 Employees
T3 - Technion Technology Transfer revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contacts at T3 - Technion Technology Transfer
Motti Koren
Director Of Business Development Life Science, Medical Device , Ai/Ml
Shikma Litmanovitz Tsury
Director Of Business Development
Arkadiy Morgenshtein
Director Of Business Development
Mor Goldfeder
Director Of Business Development, Biotech And Pharma
Ilana Shalev
Director Of Operations & Project Management
Company overview
| Headquarters | Haifa, Haifa District, Israel |
| Phone number | +97248294851 |
| Websites | |
| NAICS | 52391 |
| Keywords | Entrepreneurship, Start Ups, Technology Transfer, Innovation, Ip Management, Licensing And Commercialization |
| Employees | 1-10 |
| Socials |
T3 - Technion Technology Transfer Email Formats
T3 - Technion Technology Transfer uses 2 email formats. The most common is {first initial} (e.g., j@dp.technion.ac.il), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@dp.technion.ac.il | 66.7% |
{first initial}{last name} | jdoe@dp.technion.ac.il | 33.3% |
About T3 - Technion Technology Transfer
T3 is the Technology Transfer office of the Technion – Israel’s first and leading Institute of Technology. T3’s mission is to cultivate Technion’s human capital and unparalleled wealth of knowledge, linking academy and industry to commercialize and democratize sustainable, high-impact technologies for the future. Our open-to-industry approach is based on the Technion’s longstanding entrepreneurial culture and a commitment to nurture relationships with prestigious industry institutions and businesses. T3 equips researchers with a wealth of resources and guidance to ensure that each discovery is ready to impact, and attract investors looking to access the Technion’s finest intellectual property and leverage our expertise to create promising spin-off companies. T3’s reflection of the innovative strength of Israel's top institute of technology is demonstrated in over 100 affiliated companies established based on the intellectual property generated at the Technion’s ecosystem. Our portfolio includes 7 publicly traded with total valuation over $13.5BD, as well as globally recognized success stories such as Azilect (Teva), Novocure (NASDAQ:NVCR), Corindus (Siemens Healthcare), Mazor (Medtronic), Pluristem (NASDAQ:PSTI), Adicet Bio (NASDAQ:ACET), Rewalk (NASDAQ : RWLK), Inray (Shamir), Invision Biometrics (Intel), Itamar Medical (Zoll Medical). The Technion is home of some of the world’s most prominent life changing technologies. Its multi tier diversified funding and investment channels allow the Technion the ability to continue to generate innovations and products. The funding is geared to serve breadth of funding needs as well as depth. T3 offers acceleration and maturation programs based on industry funded research and applied research funds, as well as investments in existing or new start-up companies from early stages to Round B.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
T3 - Technion Technology Transfer has 5 employees across 2 departments.
Departments
Number of employees
Funding Data
T3 - Technion Technology Transfer has never raised funding before.
United Arab Emirates
United States
South AfricaFrequently asked questions
4.8
40,000 users
